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An antiserum to tryptophan hydroxylase purified from whole rat brain when incubated with rat striatal 
synaptosomes in the presence of complement caused release of 18% of LDH, 20% loss of potassium and 
60% loss of tryptophan hydroxylase. Uptake of S-HT was reduced by 60%. Anti-tr~tophan hydroxylase 
alone, or complement alone were without action. The antiserum plus complement had no effect on DA up- 
take and did not release TH or GAD. These results suggest selective lysis of serotonergic nerve terminals 
had occurred. The antiserum plus complement reduced choline uptake by 45%. However, this did not seem 
due to fysis of cholinergic terminals, as ChAT was not released. 
Synaptosome Serotonergic nerve terminal 
1. INTRODUCTION 
It is possible to investigate the presence of cell 
surface antigens on synaptosomes by monitoring 
the immunolysis which occurs after exposure of 
these preparations to a specific antibody and a 
source of complement [l-3]. 
We recently reported that antisera to choline 
acetyltransferase (ChAT), glutamate decarbox- 
ylase (GAD) and tyrosine hydroxylase (TH) 
evoked complement-mediated lysis of specific sub- 
populations of synaptosomes prepared from both 
the cerebral cortex and corpus striatum of rat [4]. 
These observations suggest hat the antisera used 
were capable of recognizing specific antigens in the 
outer face of the synaptosomal membrane. 
We now describe a similar effect produced by an 
antiserum to tryptophan hydroxylase, purified 
from whole rat brain. This antiserum, in the 
presence of complement, appears to lyse seroto- 
nergic synaptosomes (prepared from the corpus 
striatum of rat) but appears not to act on 
dop~inergic or GABAergic nerve terminals. 
Choline uptake into the treated striatal synap- 
tosomes is reduced. However, this action is ap- 
Lysis Antiserum Tryptophan hydroxylase 
parently not associated with the immunolysis of 
cholinergic nerve terminals. 
2. MATERIALS AND METHODS 
Tryptophan hydroxylase was purified from 
whole rat brain (full details to be published 
elsewhere). Briefly, brains were homogenized in an 
activating medium containing 50 mM Tris-HCl 
(pH 8), 20 mM dithiothreitol, 2 mM Ca2+, 50pM 
Fe2+ and 0. I mM phenylmethylsulphonylfluoride, 
and after centrifugation, the resulting supernatant 
was applied to a 6,7-dimethyl-5,6,7,8-tetrahy- 
dropterine affinity column. After rinsing, the en- 
zyme was eluted with 10 mM NaHC03 buffer (pH 
10.8) containing 0.1 mg/ml catalase. The enzyme 
was then subjected to phenyl-Sepharose and finally 
hydroxyapatite chromatography. The hydroxyapa- 
tite fractions from 5 purifications (which had a 
specific activity of about 370 nmol/min per mg 
protein and were pure according to the criterion of 
SDS electrophoresis) were concentrated to about 
500~1 and injected at g-day intervals sub- 
cutaneously into the rabbit. The first 3 injections 
contained Freund’s complete adjuvant. Eight days 
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after the final injection, the rabbit was killed, the 
blood collected and the serum prepared. The 
presence in the serum of antibodies to tryptophan 
hydroxylase was tested by immunoprecipitation 
and immunoblotting. 
Lyophilized guinea pig complement, obtained 
from Gibco, was prepared for use as in [4]. 
The sodium-dependent uptake of 5-[ 1,2(n)- 
3H]hydroxytryptamine creatinine sulphate (23.4 
Ci/mmol, New England Nuclear) into rat corpus 
striatal synaptosomes was measured at 0.05-2 PM 
5-HT as in [4] in the presence of ascorbic acid 
(0.1 mg/ml) and nialamide (10 PM). Uptake of 
5-HT was also assayed in synaptosomes that had 
been lysed by the addition of 0.25% (v/v) Triton 
X-100. Eadie-Hofstee plots of I/ vs V/S were con- 
structed to determine V,,, and K, values for the 
uptake process. Straight lines were fitted to the 
data by linear regression. 
The sodium-dependent uptake of [3H]choline 
(15 Ci/mmol, Amersham) and [2,5,6-3H]dopa- 
mine hydrochloride (9.6 Ci/mmol, Amersham) at 
0.125 PM was also measured [4]. 
Tryptophan hydroxylase activity was measured 
essentially as described in [5] by the formation of 
5-hydroxy[4-3H]tryptophan from [5-3H]trypto- 
phan (27.6 Ci/mmol, New England Nuclear), and 
the subsequent acid-dependent quantitative release 
of 3H as 3H~0; unreacted substrate being removed 
by activated charcoal. Catalase (0.5 mg/ml) was 
included in the incubation mixture. 
ChAT activity was measured using 0.4 mM 
[l-‘4C]acetyl coenzyme A (4 mCi/mmol, Amer- 
sham) as in [6] using incubation volumes of 35 ~1. 
GAD activity was assayed by the production of 
14C02 from L-[l-‘4C]glutamic acid (59 mCi/ 
mmol, Amersham), at a final concentration of 
2.5 mM as described [2]. 
Tyrosine hydroxylase activity was assayed by the 
production of [3H]dopa from L-[2,6-3H]tyrosine 
(40 Ci/mmol, Amersham) using columns of ac- 
tivated aluminium oxide to trap reaction products. 
Incubations of 75 ~1 volume were performed in 
Eppendorf tubes, and contained 10pM tyrosine, 
100 PM sodium acetate (pH 5.Q 6-methyl-5,6,7,8- 
tetrahydropterine in 28 mM mercaptoethanol and 
catalase (0.5 mg/ml). After 20 min incubation at 
37°C the reaction was stopped by the addition of 
1 ml 0.4 N HC104. The tubes were then centri- 
fuged at 10000 x g for 5 min at 4°C. To the super- 
natant was added 6.5 ml of 1.55% disodium 
EDTA and 80 mM KHzP04. This solution was 
adjusted to pH 8.6 and passed over an aluminium 
oxide column (approx. 400 mg). The column was 
washed with 20 ml water. The reaction products 
were eluted with 4 ml of 0.5 N acetic acid. This 
was mixed with 11 ml ACS II scintillant (Amer- 
sham International) for subsequent radioactivity 
counting. Recovery from the column was routinely 
50%. Lactate dehydrogenase (LDH) activity [7], 
potassium levels [4] and protein content [8] were 
measured as described. 
The actions of the antiserum were tested essen- 
tially as in [2,4] by incubating striatal synap- 
tosomes (500-1000 yg/ml) with (a) antisera 
(20-250 ~1) plus complement (l/20 of final 
volume), (b) antisera alone (20-250~1), (c) com- 
plement alone (l/20 of final volume), (d) non- 
immune serum (20-250 ~1) plus complement (l/20 
of final volume) or (e) phosphate buffer alone in a 
total volume of 0.5-1.0 ml for 30 min at 37°C. 
After incubation the synaptosomes were deposited 
by centrifugation at 10000 x g for 30 s. The super- 
natant was retained for the measurement of tryp- 
tophan hydroxylase, ChAT, GAD, tyrosine 
hydroxylase and LDH activity. After surface 
washing, the pellet was resuspended in Krebs- 
phosphate medium. An aliquot of the synap- 
tosomal suspension (500-1000 pg/ml) was used to 
measure 5HT, choline and dopamine uptake, to 
assay for tryptophan hydroxylase, ChAT, GAD, 
tyrosine hydroxylase and LDH activities, and to 
measure potassium content. 
Release of enzymes from synaptosomes due to 
the combined action of antiserum plus comple- 
ment could thus be calculated, and was expressed 
as a percentage of the total after subtraction of the 
amount present in the incubation medium at the 
start of the incubation and that due to non-specific 
release. 
3. RESULTS AND DISCUSSION 
When the antiserum (50~1) was incubated with 
the phenyl-Sepharose luted fraction (250 ~1) at 
4°C for 15 h and then centrifuged, no tryptophan 
hydroxylase activity remained in the supernatant. 
Normal rabbit serum was incapable of such 
immunoprecipitation. 
Immunoblotting tests revealed only one major 
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band which corresponded to the major stained 
band obtained on a gradient polyacrylamide slab 
gel, run under non-denaturing conditions. 
When striatal synaptosomes were incubated with 
different dilutions of anti-tryptophan hydroxylase 
serum in the presence of complement, lysis occur- 
red as reflected by the release of LDH into the 
supernatant to a maximum of 18% of the total pre- 
sent (fig.1). The response was proportional to the 
amount of antibody used, with optimal concentra- 
tions lying between 0.8 and 1.0~1 antiserum/pg 
synaptosomal protein, With optimal amounts of 
antibody, the potassium content of the treated 
synaptosomes was reduced to 80% of untreated 
controls (control values 201 & 15 nequiv./mg pro- 
tein, mean rt SD, n = 4) 5-HT uptake into these 
treated synaptosomes was reduced to 40% of con- 
trol values (fig. 1). Tryptophan hydroxylase activi- 
ty was not detected in the supernatant obtained 
after centrifuging treated synaptosomes. However, 
measurement of the enzyme activity in the pelleted 
synaptosomes revealed that after exposure to a 
mixture of antisera and complement, up to 60% of 
the enzyme activity had been lost (fig.2). Such loss 
did not occur after exposure of synaptosomes to 
antisera alone. 
This suggests that after exposure to both an- 
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Fig.1. Uptake of 5-HT into (0) and release of LDH 
from (0) striatal synaptosomes treated with anti- 
tryptophan hydroxylase serum plus complement, 
Separate synaptosome preparations were used for each 
dose of antiserum tested. Uptake of 5-HT into control 
synaptosomes, using O.OSaM 5-HT was 12 +- 
2.3 pmol/2 min per mg (mean f SD, n = 5). Total LDH 
activity in control synaptosomes was 1.3 * 
0.15 Fmol/min per mg (mean + SD, n = 4). 
tisera and complement, striatal serotonergic synap- 
tosomes are lysed with both a loss of 5HT uptake 
and a release of tryptophan hydroxylase. A loss of 
5HT uptake also occurs after lysis of synap- 
tosomes using Triton X-100. The V,,, for the pro- 
cess is then reduced to 20 pmol/2 min per mg and 
the Km increased to 8.5 PM, the correlation coeffi- 
cient for the plot of V vs V/S being -0.54 (3 
separate synaptosome preparations, 5 substrate 
concentrations used in each). Tryptophan hydrox- 
ylase released during immunolysis cannot be 
detected in the medium. This could be because an- 
tibodies to the enzyme are inhibiting its activity, as 
it is known to inhibit the purified enzyme (not 
shown). However, since there was no loss of activi- 
ty during incubation with antiserum alone, it is 
unlikely that antibodies were able to penetrate 
synaptosomes and inactivate the soluble tryp- 
tophan hydroxylase within. Also, any enzyme 
bound to the outer surface of the synaptosome 
membrane must be a relatively small proportion of 
the total tissue activity approximating to the level 
of error in the assay method. Alternatively, it 
could reflect the inherent instability of the free en- 
zyme, when unprotected in incubation media. 
That such immunolysis was selective for 
serotonergic terminals in the striatum was 
demonstrated by the absence of TH and GAD 
release (total control values 120 f 13 and 580 f 
60 pmol/min per mg, respectively, mean f SD, n 
1 2 
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Fig.2. Loss of tryptophan hydroxylase activity from 
striatal synaptosomes treated with anti-tryptophan 
hydroxylase serum plus complement (0) and anti- 
tryptophan hydroxylase serum alone (0). Total 
tryptophan hydroxylase activity in untreated 
synaptosomes was 8.3 + 0.6 pmol/min per mg (mean + 
SD, n = 7). 
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= 8 and total values after exposure to antibody 
and complement 135 f 25 and 620 f 70 pmol/min 
per mg, respectively, mean +- SD, n = 5) and the 
lack of action on dopamine uptake (control uptake 
62 f 9 pm0112 min per mg, mean + SD, n = 9 and 
uptake after exposure to antibody and complement 
70 f 12 pmol/2 min per mg, mean + SD, n = 4). 
However, choline uptake was reduced by this treat- 
ment. This effect did not seem to be caused by the 
lysis of cholinergic terminals as ChAT was not 
released (fig.3), and is therefore likely to reflect a 
direct action on the choline transport system. 
The results reported here suggest that an an- 
tiserum against tryptophan hydroxylase, in the 
presence of complement, will cause specific lysis of 
serotonergic synaptosomes. Tryptophan hydrox- 
ylase has been considered to exist in both a soluble 
and particulate form [9]. However, it has been sug- 
gested that this merely reflects its presence in cell 
bodies and nerve terminal regions respectively. Im- 
munological studies indicate that the same an- 
tibody reacts with the ‘soluble’ form in 5HT cell 
bodies and the ‘particulate’ form in 5-HT nerve 
terminals in the septum [lo]. However, Joh et al. 
[lo] observed that the tryptophan hydroxylase was 
associated with endoplasmic reticulum in the cell 
bodies and with neurotubules in terminal regions. 
If the tryptophan hydroxylase present in striatal 
synaptosomes i  associated with neurotubules, it is 
possible that the enzyme is exposed at the outer 
surface of the synaptosome during vesicular ex- 
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Fig.3. Uptake of choline into (0) and release of ChAT 
from (0) striatal synaptosomes treated with anti- 
tryptophan hydroxylase serum plus complement. 
Uptake of choline into control synaptosomes, using 
0.125 PM choline, was 40 + 5 pmol/2 min per mg 
(mean f SD, n = 4). Total ChAT activity in control 
synaptosomes was 736 & 90 pmol/min per mg (mean + 
t81 
191 
SD, n = 4). 1101 
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ocytosis, thus allowing antiserum and complement 
to interact. 
However, our results might also be explained by 
the existence of a peptide chain common to both 
tryptophan hydroxylase and a synaptosomal mem- 
brane component which serves as a phenotypic 
marker for serotonergic nerve terminals. Results 
obtained previously using antisera against ChAT, 
GAD and TH [1,2,4] have suggested that this 
phenomenon might apply to many neurotransmit- 
ter systems. These cell surface antigens may be 
very important in phenotypic classification in the 
mammalian CNS. 
NOTE ADDED IN PROOF 
Concerning the details of the purification of 
tryptophan hydroxylase referred to in section 2 as 
to be published elsewhere, this work has now been 
accepted for publication: Cash, C.D., Vayer, P., 
Mandel, P. and Maitre, M. (1985) Eur. J. 
Biochem., in press. 
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